APOE and Alzheimer disease: As noted above, APOE4 is a shared risk factor for both AD and Parkinson’s disease dementia (PDD), and there is evidence for an APOE-genotype effect on multiple aspects of protein aggregation, inflammation, and neurodegeneration across several distinct diseases including AD and PDD [168–171].